Adam Gonzalez1, Fred Friedberg1, Xiaotong Li1, Michael J Zvolensky2,3, Evelyn J Bromet1, Brittain L Mahaffey1, Anka A Vujanovic2,4, Benjamin J Luft5, Roman Kotov1. 1. Department of Psychiatry, Stony Brook University, Stony Brook, NY. 2. Department of Psychology, University of Houston, Houston, TX. 3. Department of Behavioral Sciences, University of Texas MD Anderson Cancer Center, Houston, TX. 4. Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, Houston, TX. 5. Department of Medicine, Stony Brook University, Stony Brook, NY.
Abstract
INTRODUCTION: The main objective was to evaluate the efficacy of an 8-session, group-based comprehensive smoking cessation and trauma management (CSC-T) treatment among daily smokers (≥5 cigarettes/day) exposed to the World Trade Center (WTC) disaster with elevated WTC-related post-traumatic stress disorder (PTSD) symptoms. METHODS: Participants (N = 90) were randomly assigned to CSC-T (N = 44; 63.6% white; 27.3% female; mean age = 51.32 ± 7.87) or comprehensive smoking cessation (CSC) alone (N = 46; 71.7% white; 28.3% female; mean age = 48.74 ± 10.66), which was comparable in length and time. Assessments included a diagnostic clinical interview and self-report measures of PTSD and respiratory symptoms, and smoking behavior, and biologically confirmed smoking abstinence. Evaluations occurred at a baseline visit, each treatment session, and at 1-, 2-, 4-, 12-, and 26-weeks post-treatment. RESULTS: The two treatments did not differ in regard to PTSD symptom improvement. After quit day (week 6), the two groups had similar 7-day (~15%) and 6-month (~20%) abstinence rates as well as average number of cigarettes smoked, and PTSD and respiratory symptoms. CONCLUSIONS: It is possible that the Cognitive Behavioral Therapy skills specific to quitting smoking, group-based support, and degree of therapist contact, that were available in both treatments may have played a role in equalizing the abstinence rates between the two conditions. Although the current study found no evidence that the CSC-T was superior to the CSC alone treatment, the abstinence rates observed were high relative to previous trials of smokers with diagnosed PTSD. Further development of smoking cessation programs tailored to the needs of smokers with PTSD symptoms continues to be needed. IMPLICATIONS: This study suggests that a CSC program aids in smoking abstinence for smokers with PTSD symptoms and that incorporating trauma management skills, may not add additional benefits for abstinence and PTSD and respiratory symptom relief. Further work is needed to improve smoking cessation efforts for smokers with PTSD symptoms.
INTRODUCTION: The main objective was to evaluate the efficacy of an 8-session, group-based comprehensive smoking cessation and trauma management (CSC-T) treatment among daily smokers (≥5 cigarettes/day) exposed to the World Trade Center (WTC) disaster with elevated WTC-related post-traumatic stress disorder (PTSD) symptoms. METHODS: Participants (N = 90) were randomly assigned to CSC-T (N = 44; 63.6% white; 27.3% female; mean age = 51.32 ± 7.87) or comprehensive smoking cessation (CSC) alone (N = 46; 71.7% white; 28.3% female; mean age = 48.74 ± 10.66), which was comparable in length and time. Assessments included a diagnostic clinical interview and self-report measures of PTSD and respiratory symptoms, and smoking behavior, and biologically confirmed smoking abstinence. Evaluations occurred at a baseline visit, each treatment session, and at 1-, 2-, 4-, 12-, and 26-weeks post-treatment. RESULTS: The two treatments did not differ in regard to PTSD symptom improvement. After quit day (week 6), the two groups had similar 7-day (~15%) and 6-month (~20%) abstinence rates as well as average number of cigarettes smoked, and PTSD and respiratory symptoms. CONCLUSIONS: It is possible that the Cognitive Behavioral Therapy skills specific to quitting smoking, group-based support, and degree of therapist contact, that were available in both treatments may have played a role in equalizing the abstinence rates between the two conditions. Although the current study found no evidence that the CSC-T was superior to the CSC alone treatment, the abstinence rates observed were high relative to previous trials of smokers with diagnosed PTSD. Further development of smoking cessation programs tailored to the needs of smokers with PTSD symptoms continues to be needed. IMPLICATIONS: This study suggests that a CSC program aids in smoking abstinence for smokers with PTSD symptoms and that incorporating trauma management skills, may not add additional benefits for abstinence and PTSD and respiratory symptom relief. Further work is needed to improve smoking cessation efforts for smokers with PTSD symptoms.
Authors: Monika A Waszczuk; Christopher J Hopwood; Benjamin J Luft; Leslie C Morey; Greg Perlman; Camilo J Ruggero; Andrew E Skodol; Roman Kotov Journal: Clin Psychol Sci Date: 2021-12-21
Authors: Mark B Powers; Brooke Y Kauffman; Anne L Kleinsasser; Eunjung Lee-Furman; Jasper A J Smits; Michael J Zvolensky; David Rosenfield Journal: Contemp Clin Trials Date: 2016-08-25 Impact factor: 2.226
Authors: Eric A Dedert; Patricia A Resick; Paul A Dennis; Sarah M Wilson; Scott D Moore; Jean C Beckham Journal: J Addict Med Date: 2019 Jul/Aug Impact factor: 4.647
Authors: Jaime Madrigano; Thomas W Concannon; Sean Mann; Sameer M Siddiqi; Ramya Chari; Laura J Faherty Journal: Int J Environ Res Public Health Date: 2021-03-06 Impact factor: 3.390